ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Novartis Trying to Buy Israeli Stem Cell Research Developer – The Jewish Press

The Jewish PressGamida Cell has proprietary technology for growing the number and density of stem cells within a specific blood sample and seeks to enhance umbilical cord blood donations for implants to cure blood cancer in adults. Currently, umbilical cord blood can …Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-CellJewish Business NewsGamida … Continue reading

2014-03-18 Michael Zand NEWS

Stem Cell Therapeutics: Moving Ahead With Cancer Stem Cell Target – Investing.com

Stem Cell Therapeutics: Moving Ahead With Cancer Stem Cell TargetInvesting.comStem Cell Therapeutics Corp., (SSS) is advancing SIRPαFc, an anti-CD47 fusion protein targeting cancer stem cells (CSCs) and bulk tumour cells (BTCs) in acute myeloid leukaemia (AML). SCT raised C$33m in capital in late 2013 to fund SIRPαFc … …read more   &nbs… Continue reading

2014-03-18 Michael Zand NEWS

Researchers create new line of human embryonic stem cells – News-Medical.net

Researchers create new line of human embryonic stem cellsNews-Medical.netResearchers at the University of Washington have successfully created a line of human embryonic stem cells that have the ability to develop into a far broader range of tissues than most existing cell lines. “These cells will allow us to gain a much … …read more   &nbs… Continue reading

2014-03-18 Michael Zand NEWS

Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-Cell – Jewish Business News

Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-CellJewish Business NewsStem cell therapies developer Gamida-Cell Ltd. has received an acquisition offer from an international pharma company, Novartis AG (NYSE:NVS; LSE: NOV; SWX: NOVZ). Elbit Medical Technologies, which has a 30.8 percent share in Gamida, said in a …Israel’s Gamida Cell gets buyout offer … Continue reading

2014-03-18 Michael Zand NEWS

Flow cytometry helps discover new stem cell in human skin – BioOptics World

Flow cytometry helps discover new stem cell in human skinBioOptics WorldScientists from the University of Auckland’s Maurice Wilkins Centre for Molecular Biodiscovery in New Zealand have, using flow cytometry, discovered new cells with stem cell properties in human skin. The discovery could lead to a range of new &#… Continue reading

2014-03-18 Michael Zand NEWS

The pros and cons of banking your baby’s stem cells – ABC30.com

The pros and cons of banking your baby’s stem cellsABC30.com(KFSN) — Umbilical cord stem cell banking can be expensive and controversial, but Jamie and Ben Page decided to bank their daughter Harlow’s stem cells, just in case. Then, “just in case” became a reality. She spins, kicks, and giggles. Like most five … …read more   &nbs… Continue reading

2014-03-18 Michael Zand NEWS

Antisense Therapeutics’ key anticancer drug trial underway in Melbourne – Proactive Investors Australia

Proactive Investors AustraliaAntisense Therapeutics (ASX: ANP) has commenced a Phase 1 Stem Cell Mobilisation Human Proof of Concept trial for its anticancer drug, ATL1102, at the Alfred Hospital in Melbourne. The drug aims to mobilise stem cells from bone marrow into the blood, … and more …read more   &nbs… Continue reading

2014-03-17 Michael Zand NEWS

Stem Cells to The Rescue: Repairing The Hearts – KSAT San Antonio

Stem Cells to The Rescue: Repairing The HeartsKSAT San AntonioDoctors said a heart transplant was her only option, but she’ll soon find out if she’ll be accepted into a new trial that could use her own stem cells to help repair the once thought irreversible damage, “or even create new blood vessels within areas … … Continue reading

2014-03-17 Michael Zand NEWS
  • 1
  • …
  • 3,230
  • 3,231
  • 3,232
  • 3,233
  • 3,234
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.